pemivibart

CHEBI:CHEBI_747131

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
dosage_form
INJECTION
route
INTRAVENOUS
marketing_start_date
20240322
package_marketing_start_date
22-MAR-24
generic_name
pemivibart
brand_name
pemgarda
brand_name_base
pemgarda
product_ndc
71851-005
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
WuXi Biologics Co., Ltd
manufacturer_name
Invivyd, Inc
spl_id
190d948c-2426-0ccc-e063-6294a90a4e7b
active_ingredient_name
PEMIVIBART
active_ingredient_strength
125 mg/mL
package_ndc
71851-005-01
package_description
4 mL in 1 VIAL (71851-005-01)
rxcui
2677811
unii
557S3L3FAP
spl_set_id
0bdc20a9-791f-9a06-e063-6394a90a84cc
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class